NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares
December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
Blue Lake Biotechnology Reports Additional Promising Clinical Data from Ongoing Pediatric Clinical Study of Intranasal RSV Vaccine BLB201
Company leaders to speak today during the open public hearing session of…
PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
Multiple well-tolerated doses with pharmacodynamic activity were identified and will be included…
Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
Multiple well-tolerated doses with pharmacodynamic activity were identified and will be included…
Lattice Semiconductor Announces Additional $100 Million Stock Repurchase Program Authorization
HILLSBORO, Ore.--(BUSINESS WIRE)--$LSCC #FPGA--Lattice Semiconductor Corporation (Nasdaq: LSCC), the low power programmable…
Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated…
Renesas Announces Additional Key Leadership Changes
TOKYO--(BUSINESS WIRE)--#LeadershipChanges--To build on the recent leadership changes announced on October 31,…